HEСъфинансиране2023–2028

NANOBIO4CAN · Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer

„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“

Период: 2023-11-01 → 2028-10-31
Финансиране от ЕС: 2 292 480 €
Участници: 20
Схема: HORIZON-TMA-MSCA-Cofund-P

Линиите свързват координатора с партньорите.

Накратко на български

Нанобиотехнологиите се използват за разработване на нови системи за доставка и насочване на лекарства при рак. Тези проучвания помагат за подобряване на терапевтичните подходи и повишаване на качеството на здравето и благополучието на хората.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer

NANOBIO4CAN is a new collaborative research & training programme of excellence for the recruitment of 24 postdoctoral fellows in the field of “Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer” led by Sabanci University Nanotechnology Research and Application Center (SUNUM) in collaboration with 3 leading Turkish research centers in life sciences: TUBITAK Marmara Research Center (TUBITAK-MAM), Koç University Research Center for Translational Medicine (KUTTAM) and Izmir Biomedicine and Genome Center (IBG). NANOBIO4CAN focuses on cancer research while providing a tailor-made accelerator programme to educate tomorrow’s researchers in a broad set of scientific, transferable, and business skills to develop the mindset of an entrepreneur in parallel to the academic career. The programme is designed around international networking, intersectoral mobility & interdisciplinary research topics to enhance the career opportunities of experienced researchers in the global market and to reach the benefits of employing creative researchers with high professional expectations in the programme’s research priorities: Drug Development; Targeting System Development; Delivery Systems and Testing & Validation Systems. Through the programme it is aimed to create roadmaps NANOBIO4CAN will deliver impact by putting research and innovation into a new role, combined with new forms of joint efforts and collaboration, as well as by engaging citizens. This postdoctoral programme will contribute to broader the impact within Europe’s economy and society, also contributing to the essential Horizon Europe Societal Challenge “Health & wellbeing”. The programme is also aligned with Horizon Europe’s Cancer Mission Area and its Health Global Challenge.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

NANOBIO4CAN is a new collaborative research & training programme of excellence for the recruitment of 24 postdoctoral fellows in the field of “Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer” led by Sabanci University Nanotechnology Research and Application Center (SUNUM) in collaboration with 3 leading Turkish research centers in life sciences: TUBITAK Marmara Research Center (TUBITAK-MAM), Koç University Research Center for Translational Medicine (KUTTAM) and Izmir Biomedicine and Genome Center (IBG).NANOBIO4CAN focuses on cancer research while providing a tailor-made accelerator programme to educate tomorrow’s researchers in a broad set of scientific, transferable, and business skills to develop the mindset of an entrepreneur in parallel to the academic career. The programme is designed around international networking, intersectoral mobility & interdisciplinary research topics to enhance the career opportunities of experienced researchers in the global market and to reach the benefits of employing creative researchers with high professional expectations in the programme’s research priorities: Drug Development; Targeting System Development; Delivery Systems and Testing & Validation Systems. Through the programme it is aimed to create roadmaps for the commercialization of the research outputs by licensing technologies of fellows in parallel while implementing their projects. NANOBIO4CAN will deliver impact by putting research and innovation into a new role, combined with new forms of joint efforts and collaboration, as well as by engaging citizens. This postdoctoral programme will contribute to broader the impact within Europe’s economy and society, also contributing to the essential Horizon Europe Societal Challenge “Health & wellbeing”. The programme is also aligned with Horizon Europe’s Cancer Mission Area and its Health Global Challenge.

Оригинален текст от CORDIS (на английски).

Участници

SABANCI UNIVERSITESI NANOTEKNOLOJI ARASTIRMA VE UYGULAMA MERKEZI SUNUM · IstanbulКоординаторТурция
ATABAY KIMYA SANAYI VE TICARET A.S. · IstanbulТурция
ATATURK UNIVERSITY · ErzurumТурция
BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIA · BratislavaСловакия
DIMOKRITIO PANEPISTIMIO THRAKIS · KOMOTINIГърция
EGE TEKNOPARK TEKNOLOJI GELISTIRMEBOLGESI ANONIM SIRKETI · IZMIRТурция
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA · GenovaИталия
GEN ERA DIAGNOSTIK SAGLIK HIZMETLERI A.S. · ISTANBULТурция
INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY · TriesteИталия
Ilko Ilac San.ve Tic.A.S. · IstanbulТурция
MSB MEDICAL SCHOOL BERLIN GMBH · BerlinГермания
ORGANO ID BIYOTEKNOLOJI LABORATUVAR HIZMETLERI SANAYI VE TICARET ANONIM SIRKETI · İzmirТурция
TECHNISCHE UNIVERSITEIT EINDHOVEN · EindhovenНидерландия
TRUSTLIFE Ventures Lab Saglik Teknolojileri A.S. · Umraniye / IstanbulТурция
TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU · AnkaraТурция
UNIVERSITE DE FRIBOURG · FribourgШвейцария
UNIVERSITE SANAYI ISBIRLIGI MERKEZLERI DERNEGI · ADANAТурция
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES · TampaСъединени щати
UNIWERSYTET IM. ADAMA MICKIEWICZA WPOZNANIU · PoznanПолша
USTAV POLYMEROV SLOVENSKEJ AKADEMIEVIED VEREJNA VYSKUMNA INSTITUCIA · BratislavaСловакия